This inventor holds 1 USPTO granted patent. Top assignee: Sygnis Bioscience Gmbh & Co Kg. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Stephanie Jomana Naim
Introduction
Stephanie Jomana Naim is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic approaches for neurological conditions. Her work focuses on the molecular mechanisms underlying local ischaemia and its sequelae.
Latest Patents
Stephanie holds a patent for a nucleic acid molecule encoding a neuronal serine-threonine protein kinase. This invention relates to a gene and the coded protein that plays a crucial role in the development of sequelae of local ischaemia. The new protein is a serine-threonine protein kinase, which offers a novel therapeutic approach to the prophylaxis and therapy of apoplexy. She has 1 patent to her name.
Career Highlights
Stephanie is currently employed at Sygnis Bioscience GmbH & Co. KG, where she continues to advance her research and innovations. Her work has garnered attention in the scientific community, contributing to the understanding of neurological disorders and potential treatments.
Collaborations
Stephanie collaborates with esteemed colleagues, including Bettina Klaussner and Rohini Kuner. These partnerships enhance her research efforts and foster innovation in the field.
Conclusion
Stephanie Jomana Naim exemplifies the spirit of innovation in biotechnology. Her contributions to the understanding of neuronal mechanisms and therapeutic approaches are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile